Skip to main content

Resources

View Resources ⇧
Close Resources

Announcements

View Announcements ⇧
Close Announcements

Tuberculosis

Lack of Weight Gain and Relapse Risk in a Large Tuberculosis Treatment Trial

0
Your rating: None
This article, published in May 2006 in the American Journal of Respiratory and Critical Care Medicine, presents research that demonstrates that if a patient is underweight or does not have a significant weight gain while on therapy the relapse rate of TB is much higher than in well nourished TB patients. easily identified, even in resource-poor settings.

Webinar: 2016 ATS/CDC/IDSA Clinical Practice Guidelines: Treatment of Drug-Susceptible Tuberculosis

0
Your rating: None

This 90-minute webinar was created for physicians, nurses, and other health professionals who treat and case manage patients with active TB.  The webinar introduced the 2016 Official American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America Clinical Practice Guidelines: Treatment of Drug-Susceptible Tuberculosis.  This training highlighted the guidelines development process, the key changes in recommendations, and discussed the evidence supporting the changes.  The webinar was originally presented on November 4, 2016.

The Century Ahead:Tuberculosis Science, Public Health and Policy

One-Day Symposium 

University of California, San Francisco, Laurel Heights Campus 

This symposium is intended for scientists, public health professionals and policymakers. The program will feature strategies necessary to contain and eliminate tuberculosis, building upon scientific and public health successes. The event coincides with the centennial of the California state tuberculosis program, established by the legislature in September 1913.

Timezone: 
PST
Location: 
United States

The top twenty papers on tuberculosis

0
Your rating: None
Which papers have provided the most interesting recent advances in tuberculosis research? Which new discoveries in pathogenesis, epidemiology, drug discovery or vaccine development have been the most important or are likely to have the highest impact to the field?

Tuberculosis

Tuberculosis (TB) is one of the infectious diseases of concern to U.S. public health officials working along with US-Mexico border and with other mobile underserved populations. This concern is based on the fact that TB case rates tend to be higher on the border and among migrating populations. TB is also a challenging disease to treat because of the long treatment period, which is complicated when an individual is migrating during treatment.

Syndicate content
Contact Us